Company: ZLAB
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001628280-25-008409
Chunk: 14

Company: Zai Lab Ltd
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 14
---
 Lab Limited, holding company, and its subsidiaries on a consolidated basis

Zai Lab Limited: Zai Lab Limited, a holding company

-101-

Zai Lab Shanghai: Zai Lab (Shanghai) Co., Ltd., a wholly-owned subsidiary of the Company

Zai Lab Suzhou: Zai Lab (Suzhou) Co., Ltd., a wholly-owned subsidiary of the Company

ZEJULA (Niraparib): An orally administered PARP 1/2 inhibitor

ZL-1102: An early clinical stage human VH antibody fragment that binds to IL-17

ZL-1218: An early clinical stage humanized anti-CCR8 IgG1 monoclonal antibody

ZL-1310: An early-stage next generation DLL3 ADC

ZL-1503: A pre-clinical IL-13 / IL-31 bi-specific antibody

1L: First line

2L: Second line

4L: Fourth Line

2015 Plan: Zai Lab Limited 2015 Omnibus Equity Incentive Plan, as amended

2017 Plan: Zai Lab Limited 2017 Equity Incentive Plan

2022 Plan: Zai Lab Limited 2022 Equity Incentive Plan

2024 Annual Report: Annual Report on Form 10-K for the year ended December 31, 2024

2024 Plan: Zai Lab Limited 2024 Equity Incentive Plan

2025 Proxy Statement: Our definitive proxy statement pursuant to Regulation 14A to be filed with the SEC not later than 120 days after the close of our fiscal year ended December 31, 2024

$: U.S. Dollar

-102-

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ZAI LAB LIMITEDDate: February 27, 2025By:/s/ Samantha (Ying) DuName:Samantha (Ying) DuTitle:Chief Executive Officer

-103-

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons in the capacities and on the dates indicated below: 

SignatureTitleDate/s/ Samantha (Ying) DuChief Executive Officer and Chairperson of the Board of DirectorsFebruary 27, 2025Saman